Taiwan clears VUNO’s AI fundus evaluation software
South Korean agency VUNO has gained the approval of Taiwan’s Meals and Drug Administration to market its AI fundus evaluation software program.
VUNO Med-Fundus AI analyses pictures of the fundus to rapidly detect areas of lesions indicative of retinal illnesses, together with diabetic retinopathy, macular illness and glaucoma.
This newest certification follows Taiwan FDA’s clearance for its different AI merchandise, VUNO-Med Chest X-ray and VUNO-Med Bone Age. Simply two months in the past, VUNO obtained Singapore‘s clearance for VUNO Med-Fundus AI.
Examine validates AIRS Medical’s AI answer for denoising 3D MR pictures
AIRS Medical, a medical AI startup from South Korea, has just lately proved in a research the aptitude of its AI-powered MRI reconstruction answer, SwiftMR, to denoise and tremendously enhance the standard of 3D MR pictures.
Primarily based on its findings, a deep neural network-based noise discount and picture high quality enchancment software outperformed the standard magnetisation-prepared fast gradient-echo (MP-RAGE) sequence in bettering MR picture high quality.
“We’re more than happy that now we have proved SwiftMR contributes to not solely decreasing time but additionally [helping] make pictures nice, ultimately [helping] radiologists learn pictures with confidence,” mentioned AIRS Medical CEO Dr Hyeseong Lee.
Qure.ai packages options utilizing NVIDIA’s MONAI package
Indian well being know-how startup Qure.ai is among the early adopters of NVIDIA’s newest open-source framework for deploying AI medical imaging purposes.
The MONAI Utility Packages (MAP) simplify the method of deploying an AI mannequin in an present healthcare ecosystem.
Qure.ai is now packaging its AI options for deployment utilizing MAPs, accelerating its medical affect, in keeping with NVIDIA.
UK-based Cambridge Cognition brings mind well being options to China
London-listed Cambridge Cognition, a supplier of cognitive evaluation check options, has entered into a brand new partnership to carry its digital well being choices to China.
The corporate just lately signed a 10-year unique licensing deal and strategic partnership with Luca Healthcare, an area developer of digital well being evaluation instruments.
Luca might be making Cambridge Cognition’s CANTAB suite of digital mind well being exams obtainable in China by way of its LucaPlex platform.
“China has over 265 million individuals aged 60 years and above, of which 40 million individuals have delicate cognitive impairment and 15 million individuals with a type of dementia. With neurodegenerative illnesses, early prognosis is the important thing to managing illness development. We are going to leverage Cambridge Cognition’s analysis, scientific know-how, and digital know-how to make obtainable superior cognitive evaluation instruments for the medical trials market and the healthcare market in China,” mentioned Luca CEO Echo Chen.